MET and nonpapillary renal cell carcinoma: In the subgroup analyses, however, the OS failed to show statistically significant difference between patients with c-Met-high tumor and those with c-Met-low tumor in both pRCC (HR = 1.36, P = 0.48) and ccRCC (HR = 1.29, P = 0.34).